(diaminocyclohexane)(diacetato)(dichloro)platinum

Subscribe to Selected New Research on (diaminocyclohexane)(diacetato)(dichloro)platinum

2 relevant articles (1 outcomes, 0 trials/studies) found for this Bio-Agent

Description: structure in first source

Also Known As:

(1R,2R-diaminocyclohexane)(trans-diacetato)(dichloro)platinum(IV); (Pt(DACH)(acetate)2Cl2); (Pt(IV)(1,2-diaminocyclohexane)(acetate)2Cl2); DACH-acetato-Pt

Relationship Network

Bio-Agent Context: Research Results

Inorganic Chemicals: 5

Platinum Compounds: 253

Cisplatin: 19140

(diaminocyclohexane)(diacetato)(dichloro)platinum: 2

Nitrogen Compounds: 35

Cisplatin: 19140

(diaminocyclohexane)(diacetato)(dichloro)platinum: 2

Chlorine Compounds: 4

Cisplatin: 19140

(diaminocyclohexane)(diacetato)(dichloro)platinum: 2

Related Diseases

1.	Neoplasms (Cancer) 03/01/1999 - "In particular, the greater activity of DACH-acetato-Pt in cisplatin-resistant wild-type p53 ovarian tumor models can be ascribed to its ability to more efficiently induce p53 protein and activate p53 functions." 03/01/1999 - "In view of the central role of the wild-type p53 tumor suppressor gene in drug-induced apoptosis, we evaluated the cytotoxicity of cisplatin and DACH-acetato-Pt in a panel of cisplatin-resistant ovarian tumor models with differing p53 status" 11/01/2001 - "1R,2R-Diaminocyclohexane(trans-diacetato)(dichloro)-platinum(IV) (DACH-acetato-Pt) is a novel platinum-based agent that is highly effective against cisplatin-resistant ovarian tumor cells" Get all the results and reference details, order at left...
2.	Ovarian Neoplasms (Ovarian Cancer) 11/01/2001 - "To probe its cellular mechanism, the effects of DACH-acetato-Pt (0-6.4 microM) on cell cycle checkpoints were examined using the ovarian cancer A2780 cell line as the model system" Get all the results and reference details, order at left...
2 Diseases and 2 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Cisplatin (Platino)
2.	Platinum
2 Drugs and Important Bio-Agents and 2 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>